TipRanks
Dexcom (MX:DXCM)
:DXCM
Mexico Market

Dexcom (DXCM) Ratios

0 Followers

Dexcom Ratios

MX:DXCM's free cash flow for Q3 2026 was $0.64. For the 2026 fiscal year, MX:DXCM's free cash flow was decreased by $ and operating cash flow was $0.25. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.74 1.88 1.47 2.84 1.99
Quick Ratio
1.40 1.59 1.28 2.48 1.83
Cash Ratio
0.43 0.43 0.21 0.36 0.35
Solvency Ratio
0.34 0.30 0.18 0.17 0.15
Operating Cash Flow Ratio
0.63 0.67 0.34 0.48 0.36
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.82 0.00 0.87
Net Current Asset Value
$ 212.60M$ 439.40M$ -80.50M$ 230.00M$ 408.90M
Leverage Ratios
Debt-to-Assets Ratio
0.22 0.22 0.40 0.41 0.40
Debt-to-Equity Ratio
0.55 0.51 1.23 1.25 1.01
Debt-to-Capital Ratio
0.35 0.34 0.55 0.56 0.50
Long-Term Debt-to-Capital Ratio
0.33 0.31 0.37 0.54 0.36
Financial Leverage Ratio
2.46 2.31 3.08 3.03 2.53
Debt Service Coverage Ratio
95.48 60.46 0.66 36.84 0.65
Interest Coverage Ratio
91.33 49.83 31.58 29.44 21.03
Debt to Market Cap
0.04 0.05 0.08 0.05 0.04
Interest Debt Per Share
3.75 3.61 6.44 6.77 5.56
Net Debt to EBITDA
0.28 0.35 2.10 2.21 2.66
Profitability Margins
Gross Profit Margin
63.42%60.10%60.46%63.19%64.72%
EBIT Margin
24.99%23.74%18.05%20.17%14.07%
EBITDA Margin
30.38%29.14%23.45%25.31%19.43%
Operating Profit Margin
23.98%19.56%14.88%16.50%13.44%
Pretax Profit Margin
24.73%23.35%17.58%19.61%13.43%
Net Profit Margin
19.41%17.94%14.29%14.95%11.73%
Continuous Operations Profit Margin
19.41%17.94%14.29%14.95%11.73%
Net Income Per EBT
78.50%76.84%81.27%76.22%87.31%
EBT Per EBIT
103.15%119.37%118.17%118.86%99.90%
Return on Assets (ROA)
15.88%13.19%8.89%8.64%6.33%
Return on Equity (ROE)
36.50%30.46%27.40%26.18%16.01%
Return on Capital Employed (ROCE)
30.70%21.72%16.89%12.69%11.01%
Return on Invested Capital (ROIC)
23.98%16.61%10.20%9.63%7.86%
Return on Tangible Assets
16.18%13.39%9.06%8.87%6.57%
Earnings Yield
3.21%3.23%1.83%1.13%0.77%
Efficiency Ratios
Receivables Turnover
4.30 3.61 3.90 3.67 3.87
Payables Turnover
6.05 5.40 4.62 4.82 4.32
Inventory Turnover
2.42 2.96 2.94 2.38 3.35
Fixed Asset Turnover
3.14 2.85 2.88 3.06 2.56
Asset Turnover
0.82 0.74 0.62 0.58 0.54
Working Capital Turnover Ratio
3.01 2.86 1.90 1.54 1.21
Cash Conversion Cycle
175.18 156.87 138.70 177.03 118.81
Days of Sales Outstanding
84.82 100.99 93.54 99.51 94.35
Days of Inventory Outstanding
150.67 123.45 124.18 153.18 109.03
Days of Payables Outstanding
60.31 67.56 79.03 75.66 84.58
Operating Cycle
235.49 224.44 217.73 252.69 203.39
Cash Flow Ratios
Operating Cash Flow Per Share
3.77 3.69 2.45 1.94 1.72
Free Cash Flow Per Share
2.93 2.76 1.56 1.33 0.78
CapEx Per Share
0.84 0.93 0.89 0.61 0.94
Free Cash Flow to Operating Cash Flow
0.78 0.75 0.64 0.68 0.46
Dividend Paid and CapEx Coverage Ratio
4.47 3.96 2.76 3.16 1.84
Capital Expenditure Coverage Ratio
4.47 3.96 2.76 3.16 1.84
Operating Cash Flow Coverage Ratio
1.02 1.04 0.38 0.29 0.31
Operating Cash Flow to Sales Ratio
0.28 0.31 0.25 0.21 0.23
Free Cash Flow Yield
3.58%4.16%2.00%1.07%0.69%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
31.77 31.01 54.61 88.46 129.24
Price-to-Sales (P/S) Ratio
6.01 5.56 7.80 13.22 15.15
Price-to-Book (P/B) Ratio
12.16 9.43 14.97 23.16 20.68
Price-to-Free Cash Flow (P/FCF) Ratio
27.94 24.04 49.89 93.57 144.72
Price-to-Operating Cash Flow Ratio
21.80 17.98 31.80 63.99 65.86
Price-to-Earnings Growth (PEG) Ratio
0.79 0.67 39.32 1.39 2.26
Enterprise Value Multiple
20.07 19.41 35.37 54.46 80.66
Enterprise Value
31.12B 26.37B 33.45B 49.93B 45.60B
EV to EBITDA
20.07 19.41 35.37 54.46 80.66
EV to Sales
6.10 5.66 8.29 13.78 15.67
EV to Free Cash Flow
28.34 24.48 53.03 97.53 149.65
EV to Operating Cash Flow
22.00 18.30 33.80 66.70 68.11
Tangible Book Value Per Share
6.46 6.79 4.88 4.95 4.96
Shareholders’ Equity Per Share
6.77 7.04 5.20 5.36 5.47
Tax and Other Ratios
Effective Tax Rate
0.21 0.23 0.19 0.24 0.13
Revenue Per Share
13.62 11.95 9.97 9.38 7.47
Net Income Per Share
2.64 2.14 1.42 1.40 0.88
Tax Burden
0.79 0.77 0.81 0.76 0.87
Interest Burden
0.99 0.98 0.97 0.97 0.95
Research & Development to Revenue
0.12 0.13 0.14 0.14 0.17
SG&A to Revenue
0.28 0.28 0.32 0.00 0.00
Stock-Based Compensation to Revenue
0.03 0.03 0.04 0.04 0.04
Income Quality
1.43 1.72 1.72 1.38 1.96
Currency in USD